Finance

Lists
Why is TPST down 2.47%?
Dive Deeper
TPST:NASDAQ
Tempest Therapeutics Inc
$0.83
-2.47%
(-0.021) 1D
$0.82
-0.78% (-0.0065)
After hours
Closed: Sep 25, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TPST...
Open
$0.87
High
$0.89
Low
$0.82
Mkt. cap
13.25M
Avg. vol.
5.19M
Volume
288.32K
52-wk high
$12.22
52-wk low
$0.74
EPS
-$4.49
Beta
-1.68
Shares outstanding
15.98M
No. of employees
4
Open
$0.87
High
$0.89
Low
$0.82
Mkt. cap
13.25M
Avg. vol.
5.19M
Volume
288.32K
52-wk high
$12.22
52-wk low
$0.74
EPS
-$4.49
Beta
-1.68
Shares outstanding
15.98M
No. of employees
4
About Tempest Therapeutics Inc
CEOStephen R. Brady
Employees4
Founded2011
HeadquartersBrisbane, California, United States
SectorBiotechnology
Analyst ratings
Based on 1 analyst giving stock ratings to TPST in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for TPST in the last 3 months
Highest
Current $0.83
$7.00 (+744.39%)
Average
$7.00 (+744.39%)
Lowest
$7.00 (+744.39%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$7.00
+744.4%
09/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
570.00K
539.00K
114.00K
1.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.03M
3.54M
5.42M
3.43M
Operating expense
3.60M
4.08M
5.54M
5.25M
Total operating expenses
3.60M
4.08M
5.54M
5.25M
Operating income
-3.60M
-4.08M
-5.54M
-5.25M
Other non operating income
-
-
-
-
EBT including unusual items
-3.51M
-4.02M
-27.70M
-5.24M
EBT excluding unusual items
-3.51M
-4.02M
-5.52M
-5.24M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.51M
-4.02M
-27.70M
-5.24M
Net profit margin
-
-
-
-
Earnings per share
-0.79
-0.62
-0.50
-0.34
Interest and investment income
86.00K
56.00K
23.00K
6.00K
Interest expense
-
-
-
-
Net interest expenses
86.00K
56.00K
23.00K
6.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.53M
-4.01M
-5.48M
-5.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps